FDA Import Refusal AEK-9186485-8/170003/1 — Cipla Ltd
The FDA refused shipment AEK-9186485-8/170003/1 from Cipla Ltd (India) on Jan 9, 2026. The refused product falls under Drugs and Biologics — OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 9, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDA85 OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75